http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-201300253-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-003
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02
filingDate 2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15dd16471bb645f47119ecfefee2e90b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b08003b76c50908c373d1b425ac7061
publicationDate 2015-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-201300253-A
titleOfInvention PREPARATION OF HIGH PURITY GADOBUTROL
abstract WHAT IS DESCRIBED IS A PROCESS FOR THE PRODUCTION OF HIGH PURITY GADOBUTROL WITH A PURITY (ACCORDING TO HPLC) OF MORE THAN 99.7OR 99.8 OR 99.9% AND THE USE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR PARENTERAL ADMINISTRATION. THE PROCESS IS CARRIED OUT BY USING SPECIFICALLY CONTROLLED CRYSTALLIZATION CONDITIONS.
priorityDate 2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70678987

Total number of triples: 19.